Applying Insulin Delivery Rate Adjustment to Non-Medical Fields

Publication ID: 24-11857763_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Applying Insulin Delivery Rate Adjustment to Non-Medical Fields,” Published Technical Disclosure No. 24-11857763_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857763_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,763.

Summary of the Inventive Concept

This inventive concept leverages the core technology of adjusting insulin delivery rates to develop novel solutions for optimizing resource allocation and predictive modeling in various non-medical industries, including agriculture, renewable energy, aquaculture, waste management, and industrial equipment maintenance.

Background and Problem Solved

The original patent addressed the pressing issue of diabetes management by adjusting insulin delivery rates based on individualized glucose profiles. However, this concept's limitations were confined to the medical field. The new inventive concept seeks to overcome these limitations by applying the core technology to entirely different industries, solving problems related to resource optimization, predictive modeling, and risk mitigation.

Detailed Description of the Inventive Concept

The new inventive concept involves adapting the insulin delivery rate adjustment technology to various non-medical fields. For instance, in agricultural settings, the system can adjust crop growth rates by predicting soil moisture levels and optimizing irrigation rates. In renewable energy systems, the method can optimize energy storage by predicting energy demand profiles. Similarly, in aquaculture, the device can monitor and control water quality by predicting water chemistry parameters. In waste management, the system can optimize waste processing rates by predicting waste accumulation profiles. Lastly, in industrial equipment maintenance, the method can predict and prevent equipment failures by analyzing real-time equipment performance data.

Novelty and Inventive Step

The new claims introduce a paradigm shift by applying the core technology of insulin delivery rate adjustment to non-medical fields, thereby providing a novel and non-obvious solution to resource allocation and predictive modeling challenges in these industries. The inventive step lies in recognizing the potential for cross-industry application and developing a system that can adapt to diverse data inputs and optimization goals.

Alternative Embodiments and Variations

Alternative embodiments of this inventive concept could include using machine learning algorithms to improve predictive modeling, integrating with existing industry-specific software and hardware, or developing modular systems that can be easily adapted to different industries. Variations may involve using different types of sensors, adjusting the frequency of data input, or incorporating additional data sources to enhance the accuracy of predictions.

Potential Commercial Applications and Market

The potential commercial applications of this inventive concept are vast, with opportunities to disrupt various industries and create new markets. The target industries include agriculture, renewable energy, aquaculture, waste management, and industrial equipment maintenance, with potential customers ranging from small-scale farmers to large-scale industrial operators.

CPC Classifications

SectionClassGroup
A A61 A61M5/1723
A A61 A61B5/14532
A A61 A61B5/4839
A A61 A61M5/142
A A61 A61M5/145
A A61 A61M5/14244
A A61 A61M5/14248
G G16 G16H20/17
G G16 G16H40/60
G G16 G16H40/67
A A61 A61B2562/0295
A A61 A61M2005/14208
A A61 A61M2205/3303
A A61 A61M2205/3553
A A61 A61M2205/3561
A A61 A61M2205/3569
A A61 A61M2205/3584
A A61 A61M2205/502
A A61 A61M2205/52
A A61 A61M2230/005
A A61 A61M2230/201
G G16 G16H10/60
G G16 G16H40/40
G G16 G16H50/30

Original Patent Information

Patent NumberUS 11,857,763
TitleAdjusting insulin delivery rates
Assignee(s)INSULET CORPORATION